Cancer Research

Clinical Trials for Pediatric Cancer Patients in Northern California

• We're a member of the Children’s Oncology Group (COG), the largest cooperative pediatric clinical trials group in the United States, meaning our clinicians and scientists conduct clinical research trials that aim to improve long-term outcomes for all children with malignant tumors.
• By participating in the COG on a national level, our research groups have helped in international efforts that have dramatically increased pediatric cancer survival rates to over 70 percent.
• Children’s is one of approximately 40 centers worldwide participating in the Head Start Consortium for Pediatric Brain Tumors, which focuses on improving the cure rate and quality of survival for the youngest children with tumors.

Early Phase/Novel Therapeutics Oncology Program

• This program provides local access to early phase I/II trials for the treatment of relapsed and refractory pediatric cancers. This includes acces to new and experimental promising drugs and treatments to children and adolescents with the most complex and difficult to treat cancers.
  
• In addition to treatment protocols, we have early phase trials in supportive care, drug metabolism and novel methods for tumor surveillance for earlier and less invasive detection.

Bridging the Gap between Research Science and Practical Medicine

• The Center for Cancer Research (CCR) at CHORI brings together basic science and clinical research in the treatment of various cancers. Our goal is to create meaningful advances in the prevention, diagnosis, and therapy of pediatric malignancies.
• Because we oversee both our medical research facility and our children’s hospital, we’re able to foster invaluable collaboration between scientists and doctors. By adopting this "bench-to-bedside" approach, we can get the right medicine into the hands of your child’s physicians that much faster.